Adma Biologics (ADMA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Adma Biologics (ADMA) over the last 13 years, with Q3 2025 value amounting to -$19.9 million.
- Adma Biologics' Other Gross PP&E Adjustments fell 12956.81% to -$19.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.9 million, marking a year-over-year decrease of 12956.81%. This contributed to the annual value of $68.1 million for FY2024, which is 473.51% up from last year.
- Adma Biologics' Other Gross PP&E Adjustments amounted to -$19.9 million in Q3 2025, which was down 12956.81% from $74.7 million recorded in Q2 2025.
- Over the past 5 years, Adma Biologics' Other Gross PP&E Adjustments peaked at $74.7 million during Q2 2025, and registered a low of -$19.9 million during Q3 2025.
- In the last 5 years, Adma Biologics' Other Gross PP&E Adjustments had a median value of $64.1 million in 2022 and averaged $57.9 million.
- Per our database at Business Quant, Adma Biologics' Other Gross PP&E Adjustments surged by 2275.93% in 2022 and then plummeted by 12956.81% in 2025.
- Quarter analysis of 5 years shows Adma Biologics' Other Gross PP&E Adjustments stood at $52.2 million in 2021, then increased by 22.76% to $64.1 million in 2022, then increased by 1.4% to $65.0 million in 2023, then grew by 4.74% to $68.1 million in 2024, then plummeted by 129.31% to -$19.9 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$19.9 million for Q3 2025, versus $74.7 million for Q2 2025 and $73.1 million for Q1 2025.